|
Volumn 31, Issue 3, 2007, Pages 919-921
|
MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome
|
Author keywords
4G 5G PAI 1 polymorphism; MTHFR C 677T mutation; Oral contraceptives; Polycystic ovarian syndrome
|
Indexed keywords
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
ORAL CONTRACEPTIVE AGENT;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
ADULT;
ARTICLE;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
DRUG CONTRAINDICATION;
FEMALE;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN;
HYPERHOMOCYSTEINEMIA;
OVARY POLYCYSTIC DISEASE;
THROMBOEMBOLISM;
THROMBOPHILIA;
ADULT;
CONTRACEPTIVES, ORAL, COMBINED;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
HYPERHOMOCYSTEINEMIA;
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
PLASMINOGEN ACTIVATOR INHIBITOR 1;
POLYCYSTIC OVARY SYNDROME;
THROMBOEMBOLISM;
THROMBOPHILIA;
|
EID: 34948910092
PISSN: 03506134
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (15)
|